Stifel downgraded Baxter International to ‘Hold’ from ‘Buy’ and slashed the price target to $25 from $36. The analysts ...

Baxter International slashed its 2025 profit forecast and posted disappointing quarterly earnings on Thursday, as lingering ...

We came across a bullish thesis on Baxter International Inc. on DeepValue Capital’s Substack. In this article, we will ...

Deerfield-based Baxter International is still feeling battered by Hurricane Helene and problems with its Novum infusion pumps ...

Healthcare company Baxter International (NYSE:BAX) met Wall Street’s revenue expectations in Q2 CY2025, with sales up 4.3% ...

Baxter International cut its 2025 profit forecast on Thursday, while quarterly earnings missed analysts' estimates due to the ...

Baxter International (NYSE:BAX) stock drops after the company's Q2 results miss consensus and Q3 projection fails to meet ...

Baxter International Inc. BAX is scheduled to release second-quarter 2025 results on July 31, before the opening bell. In the ...

Baxter International Inc. closed 30.72% below its 52-week high of $40.49, which the company achieved on September 17th.

Baxter International BAX 1.10% is selling its kidney care segment to Carlyle CG 2.06% Group for $3.8 billion, most of which will be paid in cash. The Deerfield, Ill., medical-device maker on ...

Drug and hospital-product manufacturer Baxter International Inc. BAX -2.26% says it has lost “multiple production days” in hurricane-wracked Puerto Rico that will delay its ability to restore ...

The stock's fall snapped a four-day winning streak.